Skip to main content
. 2026 Mar 13;18(6):944. doi: 10.3390/cancers18060944
UM uveal melanoma
BT brachytherapy
PT proton therapy
SRT stereotactic radiotherapy
SRS stereotactic radiosurgery
TTT transpupillary thermotherapy
PDT photodynamic therapy
Ru-106 ruthenium-106
I-125 iodine-125
COMS Collaborative Ocular Melanoma Study
IOL intraocular lens
BCVA best corrected visual acuity
USG ultrasonography
UBM ultrasound biomicroscopy
AJCC American Joint Committee on Cancer
OCT optical coherence tomography
CGE Cobalt Gray Equivalent
Anti-VEGF anti-vascular endothelial growth factor
TCA triamcinolone acetonide
SD standard deviation
Ru-106 CCB brachytherapy ruthenium-106 brachytherapy with CCB plaque
Ru-106 COB brachytherapy ruthenium-106 brachytherapy with COB plaque
Ru-106 CCB (in tables) ruthenium-106 brachytherapy with CCB plaque
Ru-106 COB (in tables) ruthenium-106 brachytherapy with COB plaque
I-125 (in tables) iodine-125 brachytherapy
mm millimeter
Gy gray
HR hazard ratio
CI confidence interval
TBUT tear break-up time